AAHI Supports the UN's Sustainable Development Goals for 2030

Last week, the 2023 SDG Summit held in New York City marked the chronological half-way point to achieving the 17 goals set out to end poverty, protect the planet, and establish global peace and prosperity. We hold ourselves accountable and responsible for progress towards the five goals that AAHI supports by developing effective, sustainable, and cost-efficient health solutions.

Houston, Texas

AAHI's partners with Baylor College of Medicine to advance a novel Chagas Vaccine Candidate to Clinical Trials

Chagas disease is caused by a parasite found in the feces of an insect called triatomine, also known as the "kissing bug" - an insect in rural Latin America that resides in thatched roofs and mud walls. The kissing bug and Chagas are migrating north -- CDC now estimates more than 300,000 people live with the parasite in the United States. Chagas disease can develop silently for years before causing sever cardiac arrest or neurological damage and, in some cases, can be fatal. People in the United States are at risk for Chagas by receiving blood transfusions, and AAHI technology already contributes to a diagnostic test that helps screen the blood supply. The vaccine being tested combines Baylor's proprietary antigen with AAHI's GLA-SE adjuvant formulation.